Peptide record

TPDB66549

ACE inhibitor ACE inhibitors standard
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB66549
ACE inhibitor
ACE inhibitors
Cardiometabolic peptides
Peptipedia
standard
No
A 6-aa standard natural ace inhibitors peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
LVLPGE
Physicochemical Analysis
C29H50N6O9
ARNDCQHIKMFSTWY
L
626.75
3.29
0
1
3
-1
1.43
1.050
178.33
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
1
G
0
H
0
I
2
L
0
K
0
M
0
F
1
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 0 L: 2 K: 0 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
6
C29H50N6O9
626.75
3.29
-1
1.43
1.050
626.7401
626.3627
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
0.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Pei J., Hua Y., Zhou T., Gao X., Dang Y., Wang Y.
Transport, in vivo antihypertensive effect, and pharmacokinetics of an angiotensin-converting enzyme (ACE) inhibitory peptide LVLPGE. J. Agric. Food Chem., 69, 2149–2156, 2021
2021
Journal

Other

6
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)NCC(=O)N[C@@]([H])(CCC(=O)O)C(=O)O InChI=1S/C29H50N6O9/c1-15(2)12-18(30)25(39)34-24(17(5)6)27(41)33-20(13-16(3)4)28(42)35-11-7-8-21(35)26(40)31-14-22(36)32-19(29(43)44)9-10-23(37)38/h15-21,24H,7-14,30H2,1-6H3,(H,31,40)(H,32,36)(H,33,41)(H,34,39)(H,37,38)(H,43,44)/t18-,19-,20-,21-,24-/m0/s1 InChIKey=VLKYKEAXTIBHRI-TVJXPIDLSA-N Hypotensive peptide according to the BIOPEP-UWM database of bioactive peptides (ID 10195)
Additional Detail Fields 1 fields
6